Delayed and long-delayed chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a scoping review of reporting gaps. [PDF]
Iimura Y +11 more
europepmc +1 more source
Postoperative nausea and vomiting: current concepts, management strategies, and future perspectives. [PDF]
Qiu L +3 more
europepmc +1 more source
Perioperative substance P/NK1R pharmacology: from PONV control to a testable cancer neuro-immune hypothesis. [PDF]
Zhao J, Liu Z, Wang J.
europepmc +1 more source
Netupitant versus aprepitant: model-predicted neurokinin-1 receptor occupancy and implications for long-delayed nausea and vomiting prevention. [PDF]
Iihara H +12 more
europepmc +1 more source
Aprepitant and Fosaprepitant for Preventing Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy-A Real-World Study. [PDF]
Ünlü B +8 more
europepmc +1 more source
Olanzapine Use and Vomiting Incidence in Chemotherapy-receiving Patients With Cervical Cancer: Multicenter Post Hoc Analysis. [PDF]
Kawamura Y +17 more
europepmc +1 more source
Potential risk of neoplasms with fezolinetant: clinical evidence, mechanisms, and post-marketing implications. [PDF]
Boretti E, Dogné JM, Douxfils J.
europepmc +1 more source
Identification of Factors Associated With Clinically Problematic Hiccups in Male Patients Receiving Cisplatin-based Treatment With Dexamethasone and Aprepitant: A Subgroup Analysis. [PDF]
Saito Y +5 more
europepmc +1 more source
The substance P/ Neurokinin-1 receptor signaling drives perineural invasion in pancreatic ductal adenocarcinoma (PDAC). [PDF]
Schiedlauske K +8 more
europepmc +1 more source
Literature Review: Recent Therapeutic Advances in The Management of Prurigo Nodularis: From Conventional Therapy to Biologics and Targeted Small-Molecule Agents. [PDF]
Avriyanti E +6 more
europepmc +1 more source

